SEC FORM
4
SEC Form 4
| FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
|
| OMB APPROVAL |
| OMB Number: |
3235-0287 |
| Estimated average burden |
| hours per response: |
0.5 |
|
|
 |
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b). |
1. Name and Address of Reporting Person*
| C/O ICU MEDICAL INC |
| 951 CALLE AMANECER |
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
ICU MEDICAL INC/DE
[ icui ]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
| X |
Director |
|
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
3. Date of Earliest Transaction
(Month/Day/Year)
08/16/2003
|
4. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
| X |
Form filed by One Reporting Person |
|
Form filed by More than One Reporting Person |
|
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
|---|
| 1. Title of Security (Instr.
3)
|
2. Transaction Date
(Month/Day/Year) |
2A. Deemed Execution Date, if any
(Month/Day/Year) |
3. Transaction Code (Instr.
8)
|
4. Securities Acquired (A) or Disposed Of (D) (Instr.
3, 4 and 5)
|
5.
Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr.
4)
|
7. Nature of Indirect Beneficial Ownership (Instr.
4)
|
| Code |
V |
Amount |
(A) or (D) |
Price |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
|
|---|
| 1. Title of Derivative Security (Instr.
3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Transaction Date
(Month/Day/Year) |
3A. Deemed Execution Date, if any
(Month/Day/Year) |
4. Transaction Code (Instr.
8)
|
5.
Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
3, 4 and 5)
|
6. Date Exercisable and Expiration Date
(Month/Day/Year) |
7. Title and Amount of Securities Underlying Derivative Security (Instr.
3 and 4)
|
8. Price of Derivative Security (Instr.
5)
|
9.
Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
4)
|
10. Ownership Form: Direct (D) or Indirect (I) (Instr.
4)
|
11. Nature of Indirect Beneficial Ownership (Instr.
4)
|
| Code |
V |
(A) |
(D) |
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
| Non-Qualified Stock Option (right to buy) |
$28.635
|
08/16/2003 |
|
A |
|
1,875 |
|
02/16/2004 |
08/16/2014 |
Common Stock |
1,875 |
$0
|
1,875 |
D |
|
| Explanation of Responses: |
|
|
By: Lynn DeMartini For: Richard H. Sherman, M.D. |
08/18/2003 |
|
** Signature of Reporting Person |
Date |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
| * If the form is filed by more than one reporting person,
see
Instruction
4
(b)(v). |
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
POWER OF ATTORNEY
SEC FORMS 3, 4 and 5
The undersigned, Richard H. Sherman, M.D., hereby
Appoints and designates each of Lynn DeMartini and
Janice Rough his attorney-in-fact, signing singly,
to execute and file on the undersigned's behalf all
Forms 3, 4, and 5 (including any amendments thereto)
that the undersigned may be required to file with
the U.S. Securities and Exchange Commission as a result
of the undersigned's ownership of or transactions in
securities of ICU Medical Inc. Any previous authority
to act on the undersigned's behalf in connection with
such execution and filing f Forms 3, 4 and 5 is hereby
revoked and the authority of Lynn DeMartini and
Janice Rough under this Statement shall continue
until the undersigned is no longer required to file
Forms 3, 4 and 5 with regard to the undersigned's
ownership of or transactions in securities of
ICU Medical Inc., unless earlier revoked in
writing. The undersigned acknowledges that neither
Lynn DeMartini nor Janice Rough is assuming any of
the undersigned's responsibilities to comply with
Section 16 of the Securities Exchange Act of 1934.
Date: August 15, 2003
/s/ Richard H. Sherman, M.D.
- ------------------------------
Richard H. Sherman, M.D.
